주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Profile

Hideki Hasegawa

HH

Hideki Hasegawa

National Institute of Infectious Diseases, Japan

Dr. Hideki Hasegawa, M.D., Ph.D., is Director of the Influenza Research Center and WHO Collaborating Centre at NIID, Japan Institute for Health Security. A virologist and pathologist, he focuses on emerging infectious diseases, mucosal immunology, and influenza vaccines. He has characterized pandemic and avian influenza pathology, investigated SFTS, and advanced intranasal inactivated influenza vaccine development. His work on secretory IgA has contributed to mucosal vaccine strategies, including a COVID-19 recombinant protein vaccine. Dr. Hasegawa earned his degrees from Hokkaido University and completed postdoctoral training at The Rockefeller University and University College Dublin.